
Now online in @CD_AACR: Activated T Cells Break Tumor Immunosuppression by Macrophage Re-education - by @RosaTrotta89, Silvia Rivis, Shikang Zhao, @LabMazzone, and colleagues doi.org/10.1158/2159-8290.CD… @VIB @KU_Leuven

Laboratory of Tumor Inflammation and Angiogenesis @VIB @KU_Leuven

Now online in @CD_AACR: Activated T Cells Break Tumor Immunosuppression by Macrophage Re-education - by @RosaTrotta89, Silvia Rivis, Shikang Zhao, @LabMazzone, and colleagues doi.org/10.1158/2159-8290.CD… @VIB @KU_Leuven

Very excited to share that the work of my PhD, where we engineer T cell metabolism to improve their antitumoral activity, is finally out in ✨ @NatMetabolism 🙏Huge thank you to @MazzoneLab and all the collaborators @vib_ccb @KU_Leuven 🔍—> sulkurl.com/n0r

🤯 Blocking an enzyme can reprogram immune cells to improve cancer treatments? Check out our latest research by @LabMazzone @samantha_pretto and colleagues @vib_ccb! @ERC_Research @Stkstichting @FWOVlaanderen 👉 Read here: vibbio.tech/41DARA0

Looking forward to the @ImmunoMetEurope conference in Denmark! #immunometabolism @vib_ccb @Onco_KULeuven

🚨Paper alert! I am delighted to share that the main work of my PhD is finally out. 🎉🎉 I would like to thank all the co-authors, especially @marta_manco26 and @LabMazzone to make it possible! Check it here: 👉nature.com/articles/s43018-0…

📜🥳Congratulations @tommaso_scolaro and @marta_manco26! @LabMazzone
Did you know pancreatic cancer is one of the most aggressive and lethal cancers in the world? Researchers at the @vib_ccb teamed up with @UZLeuven to investigate ways to bypass immunotherapy resistance. Read more about it here ▶️ vibbio.tech/3x7hRPc

After the poster session, Jingjing Zhu (@UCLouvain_be ) walks us through new targets improving immunotherapy outcome across multiple tumor types! - MPO #ImmunoOnco24

Its always nice to see many upcoming scientists present their work at #ImmunoOnco24! A lot of interesting stories, can’t wait to read more about those in the coming years! -MPO

Don’t be scared about @IMalanchi’s talk! Her lab combines neutrophil research, metabolism and metastasis 😬🤩 Fascinating research on tumor-host interaction that she showed today at #ImmunoOnco24 - MPO @TheCrick

Another day at the conference means another day to keep you updated on great talks #ImmunoOnco24 Starting the day with a talk of @Casanova_Acebes @CNIOStopCancer. Very interesting presentation on myeloid cells and their roles in tumor progression!
Excited for day 2 of VIB's #ImmunoOnco24 conferece 🤩 Today we'll share our updates on the myeloid cells, tumor-host interactions, immunotherapy and translational research sessions 💬 Follow along via @AgostinisLab, @LabMazzone and this avcount to avoid FOMO✌️

Last talk of today at #ImmunoOnco24, a tango 💃 by @gabyrabi @RabinovichLab starring galectins and glycans. Clear presentation on a complex topic. -MPO @VIBConferences

We continue the day with a fascinating talk of @RetickerFlynn @Stanford on lymph node metastasis and how this changes the immune landscape and influences distant metastatic spreading and immune tolerance . -MPO #ImmunoOnco24

Listening to new developments of @MariaThemeli1 to overcome CAR-T cell shortcomings. Engineering the right combinations to bring the best to the clinics, let the magic happen! - MPO #ImmunoOnco24

🚨Deadline alert! 8 days left to register to #ImmunoOnco24! Jingjing Zhu @UCLouvain_be will present the work of her lab on novel immunotherapies. Registration closes 16th of May. More info: vibconferences.be/events/rec… -MPO

Double interview with @LabMazzone and @deVisserKarin! Discover their research, inspirations, the importance of a strong scientific network, and the VIB #ImmunoOnco24 conference. Read more about it here 👉 vibbio.tech/3TYC6pB Early bird tickets are available until 18 April!

‼️ Few days left until the early bird deadline. @RetickerFlynn @Stanford will give a talk on systemic immunity in metastasis. Don’t miss it out, join us in Antwerp! -MPO 📅 Early bird: 18th of April ℹ️ vibconferences.be/events/rec… @vib_ccb @VIBConferences